Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis
Introduction. The use of extreme lateral interbody fusion (XLIF) and other lateral access surgery is rapidly increasing in popularity. However, limited data is available regarding its use in scoliosis surgery. The objective of this study was to evaluate the clinical outcomes of adults with degenera...
Saved in:
Main Authors: | Adam M. Caputo, Keith W. Michael, Todd M. Chapman, Gene M. Massey, Cameron R. Howes, Robert E. Isaacs, Christopher R. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/680643 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stand-Alone Lateral Interbody Fusion for the Treatment of Low-Grade Degenerative Spondylolisthesis
by: Luis Marchi, et al.
Published: (2012-01-01) -
Clinical Outcome and Fusion Rates after the First 30 Extreme Lateral Interbody Fusions
by: Gregory M. Malham, et al.
Published: (2012-01-01) -
Allograft Cellular Bone Matrix in Extreme Lateral Interbody Fusion: Preliminary Radiographic and Clinical Outcomes
by: Antoine G. Tohmeh, et al.
Published: (2012-01-01) -
DEGENERATIVE SCOLIOSIS: A CASE REPORT
by: I Ketut Martiana, et al.
Published: (2019-12-01) -
Efficacy and safety of long fusion versus short fusion in degenerative scoliosis: a systematic review and meta-analysis
by: Bin Zheng, et al.
Published: (2025-01-01)